Harrow, S., Hanna, G.G., Faivre-Finn, C., McDonald, F. and Chalmers, A. (2016) The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer. Clinical Oncology, 28(11), pp. 720-725. (doi: 10.1016/j.clon.2016.08.004) (PMID:27591000)
|
Text
128261.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 577kB |
Abstract
Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Chalmers, Professor Anthony |
Authors: | Harrow, S., Hanna, G.G., Faivre-Finn, C., McDonald, F., and Chalmers, A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Clinical Oncology |
Publisher: | Elsevier |
ISSN: | 0936-6555 |
ISSN (Online): | 1433-2981 |
Published Online: | 31 August 2016 |
Copyright Holders: | Copyright © 2016 Elsevier |
First Published: | First published in Clinical Oncology 28(11):720-725 |
Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record